Guillaume Butler-Laporte

Aug 22, 2024 | cell.com | Guillaume Butler-Laporte |Kevin Liang |Metabolic Diseases |Claudia Langenberg

1Department of Human Genetics, McGill University, Montréal, QC, Canada 2Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, QC, Canada 3Division of Infectious Diseases, Department of Medicine, McGill University 4Quantitative Life Sciences Program, McGill University, Montreal, Quebec, Canada 5Computational Medicine, Berlin Institute of Health at Charité—Universitätsmedizin Berlin, Berlin, Germany 6Tanaka Diabetes Clinic Omiya, Saitama, Japan 7Department of Diabetes and...

Jul 11, 2024 | medrxiv.org | Fergus W Hamilton |Todd Lee |Guillaume Butler-Laporte

The authors have declared no competing interest. FHs time was funded by the NIHR Clinical Lectureship scheme. I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Feb 20, 2023 | nature.com | Satoshi Yoshiji |Guillaume Butler-Laporte |Tianyuan Lu |Chen-Yang Su |Tomoko Nakanishi |David Morrison | +5 more

AbstractObesity is a major risk factor for Coronavirus disease (COVID-19) severity; however, the mechanisms underlying this relationship are not fully understood. As obesity influences the plasma proteome, we sought to identify circulating proteins mediating the effects of obesity on COVID-19 severity in humans. Here, we screened 4,907 plasma proteins to identify proteins influenced by body mass index using Mendelian randomization.